MCOV B — Medicover AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK31.25bn
- SEK45.69bn
- €2.09bn
- 75
- 20
- 41
- 38
Annual cashflow statement for Medicover AB, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 37.3 | 144 | 19.8 | 23.6 | 20.1 |
| Depreciation | |||||
| Non-Cash Items | 34.2 | 21.1 | 47.5 | 42.2 | 64.4 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.7 | -59.2 | -59 | -43.2 | -37 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 156 | 217 | 170 | 205 | 262 |
| Capital Expenditures | -72.5 | -102 | -141 | -111 | -122 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -53.8 | -231 | -44.2 | -9.3 | -12.4 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -126 | -334 | -185 | -120 | -135 |
| Financing Cash Flow Items | -18.2 | -26 | -45.3 | -54.9 | -146 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.1 | 164 | -24.3 | -73.7 | -108 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.9 | 35.2 | -41.5 | 10.4 | 19.2 |